Dr. Thomas Young, M.D

NPI: 1346259710
Total Payments
$20,931
2020 Payments
$4,400
Companies
2
Transactions
16

Payment Breakdown by Category

Consulting$20,800 (99.4%)
Food & Beverage$131.07 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $20,800 14 99.4%
Food and Beverage $131.07 2 0.6%

Top Paying Companies

Company Total Records Latest Year
GW Research Limited $20,800 14 $0 (2020)
Chiesi USA, Inc. $131.07 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2020 $4,400 2 GW Research Limited ($4,400)
2019 $16,400 12 GW Research Limited ($16,400)
2018 $105.04 1 Chiesi USA, Inc. ($105.04)
2017 $26.03 1 Chiesi USA, Inc. ($26.03)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/08/2020 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $3,200.00 General
Category: Neurology
09/08/2020 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: Neurology
10/18/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $800.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $4,000.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $3,400.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $3,200.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $1,600.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $800.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $600.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $200.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $200.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $200.00 General
Category: Neurology
07/31/2019 GW Research Limited Epidiolex (Drug) Consulting Fee Cash or cash equivalent $200.00 General
Category: Neurology
03/04/2018 Chiesi USA, Inc. CUROSURF (Drug) Food and Beverage Cash or cash equivalent $105.04 General
Category: NEONATOLOGY
05/07/2017 Chiesi USA, Inc. CUROSURF (Drug) Food and Beverage Cash or cash equivalent $26.03 General
Category: NEONATAL

About Dr. Thomas Young, M.D

Dr. Thomas Young, M.D is a Pediatrics healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346259710.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Young, M.D has received a total of $20,931 in payments from pharmaceutical and medical device companies, with $4,400 received in 2020. These payments were reported across 16 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($20,800).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Neonatal-Perinatal Medicine
  • Location Raleigh, NC
  • Active Since 08/05/2006
  • Last Updated 12/30/2021
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1346259710

Products in Payments

  • Epidiolex (Drug) $20,800
  • CUROSURF (Drug) $131.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Raleigh